• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻运动员肥厚型心肌病的筛查。

Screening for hypertrophic cardiomyopathy in young athletes.

作者信息

Corrado D, Basso C, Schiavon M, Thiene G

机构信息

Department of Cardiology, University of Padua, Italy.

出版信息

N Engl J Med. 1998 Aug 6;339(6):364-9. doi: 10.1056/NEJM199808063390602.

DOI:10.1056/NEJM199808063390602
PMID:9691102
Abstract

BACKGROUND

For more than 20 years in Italy, young athletes have been screened before participating in competitive sports. We assessed whether this strategy results in the prevention of sudden death from hypertrophic cardiomyopathy, a common cardiovascular cause of death in young athletes.

METHODS

We prospectively studied sudden deaths among athletes and nonathletes (35 years of age or less) in the Veneto region of Italy from 1979 to 1996. The causes of sudden death in both populations were compared, and the pathological findings in the athletes were related to their clinical histories and electrocardiograms. Cardiovascular reasons for disqualification from participation in sports were investigated and follow-up was performed in a consecutive series of 33,735 young athletes who underwent preparticipation screening in Padua during the same period.

RESULTS

Of 269 sudden deaths in young people, 49 occurred in competitive athletes (44 male and 5 female athletes; mean age, 23+/-7 years). The most common causes of sudden death in athletes were arrhythmogenic right ventricular cardiomyopathy (22.4 percent), coronary atherosclerosis (18.4 percent), and anomalous origin of a coronary artery (12.2 percent). Hypertrophic cardiomyopathy caused only 1 sudden death among the athletes (2.0 percent) but caused 16 sudden deaths in the nonathletes (7.3 percent). Hypertrophic cardiomyopathy was detected in 22 athletes (0.07 percent) at preparticipation screening and accounted for 3.5 percent of the cardiovascular reasons for disqualification. None of the disqualified athletes with hypertrophic cardiomyopathy died during a mean follow-up period of 8.2+/-5 years.

CONCLUSIONS

The results show that hypertrophic cardiomyopathy was an uncommon cause of death in these young competitive athletes and suggest that the identification and disqualification of affected athletes at screening before participation in competitive sports may have prevented sudden death.

摘要

背景

在意大利,20多年来一直对年轻运动员进行参赛前筛查。我们评估了这一策略是否能预防肥厚型心肌病导致的猝死,肥厚型心肌病是年轻运动员常见的心血管死亡原因。

方法

我们对1979年至1996年意大利威尼托地区运动员和非运动员(35岁及以下)的猝死情况进行了前瞻性研究。比较了两组人群的猝死原因,并将运动员的病理检查结果与其临床病史和心电图相关联。调查了因心血管原因被取消参赛资格的情况,并对同期在帕多瓦接受参赛前筛查的33735名年轻运动员进行了连续随访。

结果

在269例年轻人猝死中,49例发生在竞技运动员中(44名男性和5名女性运动员;平均年龄23±7岁)。运动员猝死的最常见原因是致心律失常性右室心肌病(22.4%)、冠状动脉粥样硬化(18.4%)和冠状动脉异常起源(12.2%)。肥厚型心肌病仅导致1例运动员猝死(2.0%),但在非运动员中导致16例猝死(7.3%)。在参赛前筛查中,22名运动员(0.07%)被检测出患有肥厚型心肌病,占取消资格的心血管原因的3.5%。在平均8.2±5年的随访期内,没有因肥厚型心肌病被取消资格的运动员死亡。

结论

结果表明,肥厚型心肌病在这些年轻竞技运动员中是一种不常见的死亡原因,并提示在参加竞技运动前筛查时识别并取消受影响运动员的资格可能预防了猝死。

相似文献

1
Screening for hypertrophic cardiomyopathy in young athletes.年轻运动员肥厚型心肌病的筛查。
N Engl J Med. 1998 Aug 6;339(6):364-9. doi: 10.1056/NEJM199808063390602.
2
Is prevention of sudden death in young athletes feasible?预防年轻运动员猝死是否可行?
Cardiologia. 1999 Jun;44(6):497-505.
3
Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies.美国和意大利年轻竞技运动员心源性猝死经历的比较及其对赛前筛查策略的启示。
Am J Cardiol. 2009 Jul 15;104(2):276-80. doi: 10.1016/j.amjcard.2009.03.037. Epub 2009 May 18.
4
Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes.意大利国家运动员参赛前肥厚型心肌病筛查项目有效性的证据。
Eur Heart J. 2006 Sep;27(18):2196-200. doi: 10.1093/eurheartj/ehl137. Epub 2006 Jul 10.
5
Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.对年轻竞技运动员进行心血管运动前筛查以预防猝死:欧洲通用方案建议。欧洲心脏病学会心脏康复与运动生理学工作组及心肌和心包疾病工作组运动心脏病学研究组共识声明
Eur Heart J. 2005 Mar;26(5):516-24. doi: 10.1093/eurheartj/ehi108. Epub 2005 Feb 2.
6
Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification.肥厚型心肌病及年轻竞技运动员心源性猝死的其他原因,以及对参赛前筛查和 disqualification 标准的考量。 注:这里“disqualification”直译为“取消资格”,结合语境可能有更专业准确的医学术语表述,比如“禁赛标准”等,可根据具体医学领域进一步优化。
Cardiol Clin. 2007 Aug;25(3):399-414, vi. doi: 10.1016/j.ccl.2007.07.006.
7
Prevention of sudden cardiac death: return to sport considerations in athletes with identified cardiovascular abnormalities.心脏性猝死的预防:患有已确诊心血管异常的运动员恢复运动的注意事项
Br J Sports Med. 2009 Sep;43(9):685-9. doi: 10.1136/bjsm.2008.054882.
8
Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program.实施赛前筛查计划后年轻竞技运动员心源性猝死的趋势
JAMA. 2006 Oct 4;296(13):1593-601. doi: 10.1001/jama.296.13.1593.
9
Sudden death in competitive athletes.竞技运动员猝死。
Clin Sports Med. 2008 Jan;27(1):153-81, ix. doi: 10.1016/j.csm.2007.09.004.
10
Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.高水平运动员中肥厚型心肌病的患病率:与赛前筛查的相关性
J Am Coll Cardiol. 2008 Mar 11;51(10):1033-9. doi: 10.1016/j.jacc.2007.10.055.

引用本文的文献

1
Italian Guidelines for Cardiological Evaluation in Competitive Football Players: A Detailed Review of COCIS Protocols.意大利职业足球运动员心脏评估指南:COCIS协议详细综述
Healthcare (Basel). 2025 Aug 7;13(15):1932. doi: 10.3390/healthcare13151932.
2
Identification of hypertrophic cardiomyopathy on electrocardiographic images with deep learning.利用深度学习在心电图图像上识别肥厚型心肌病。
Nat Cardiovasc Res. 2025 Jul 22. doi: 10.1038/s44161-025-00685-3.
3
Hypertrophic Cardiomyopathy: New Clinical and Therapeutic Perspectives of an "Old" Genetic Myocardial Disease.
肥厚型心肌病:一种“古老”的遗传性心肌病的新临床与治疗视角
Genes (Basel). 2025 Jan 10;16(1):74. doi: 10.3390/genes16010074.
4
Sex Differences in the Incidence of Sudden Cardiac Arrest/Death in Competitive Athletes: A Systematic Review and Meta-analysis.竞技运动员心脏性猝死发生率的性别差异:一项系统评价与荟萃分析
Sports Med. 2025 Mar;55(3):697-712. doi: 10.1007/s40279-024-02163-5. Epub 2025 Jan 3.
5
Prevalence and Clinical Significance of Early Repolarization in Athletes: A Systematic Review.运动员早期复极的患病率及临床意义:一项系统评价
Ann Noninvasive Electrocardiol. 2025 Jan;30(1):e70032. doi: 10.1111/anec.70032.
6
Storytelling of Hypertrophic Cardiomyopathy Discovery.肥厚型心肌病发现的故事讲述
J Cardiovasc Dev Dis. 2024 Sep 28;11(10):300. doi: 10.3390/jcdd11100300.
7
Austrian consensus statement on the diagnosis and management of hypertrophic cardiomyopathy.奥地利肥厚型心肌病诊断与管理共识声明
Wien Klin Wochenschr. 2024 Oct;136(Suppl 15):571-597. doi: 10.1007/s00508-024-02442-1. Epub 2024 Oct 1.
8
The International Criteria for Electrocardiogram Interpretation in Athletes: Common Pitfalls and Future Directions.国际运动员心电图解读标准:常见误区与未来方向。
Card Electrophysiol Clin. 2024 Mar;16(1):35-49. doi: 10.1016/j.ccep.2023.09.006.
9
Identification of Hypertrophic Cardiomyopathy on Electrocardiographic Images with Deep Learning.利用深度学习在心电图图像上识别肥厚型心肌病
medRxiv. 2023 Dec 28:2023.12.23.23300490. doi: 10.1101/2023.12.23.23300490.
10
The Role of miRNA Expression Profile in Sudden Cardiac Death Cases.miRNA 表达谱在心脏性猝死病例中的作用。
Genes (Basel). 2023 Oct 17;14(10):1954. doi: 10.3390/genes14101954.